The411Now11 hours agoU.K. becomes first in world to OK Moderna's updated COVID-19 boosterAxios - Erin DohertyRegulators in the United Kingdom on Monday approved a COVID-19 booster for adults that targets both the original virus and the Omicron variant. Why it …
The411Now6 hours agoNovavax seeks FDA authorization of COVID vaccine boosterAxios - Julia ShaperoNovavax is seeking emergency authorization of its COVID-19 booster shot from the Food and Drug Administration, the company announced on Monday. The …
The411Now1 day agoWhy monkeypox is a repeat of the data mistakes made with Covid-19verified_publisherVox - Miranda Dixon-LuinenburgThe US declared monkeypox a public health emergency this month, but the decision may have come too late. Though states are now required to report cases, and commercial labs have an approved test, a testing bottleneck persists, and cases — which passed 10,000 confirmed cases this week — are likely …
The411Now22 hours agoLyme disease vaccine: Pfizer, Valneva launch trials for first shot in 20 yearsMedical News Today - Robby BermanLyme disease is a growing problem, the debilitating condition is most commonly caused by the bacteria Borrelia burgdorferiwhich can be transferred by …
The411Now8 hours agoPfizer CEO tests positive for COVID-19kcbd.com - Associated Press(AP) - The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild …
The411Now1 day ago‘Left to rot’: The lonely plight of long Covid sufferersverified_publisherPOLITICO - By Daniel PayneSome studies suggest long Covid could affect as much as 30 percent of people who are infected. Thousands of long Covid patients across the globe are urging their governments to provide more help for the growing number of people facing lingering symptoms after infection. At least 90 long Covid groups …
/cloudfront-us-east-1.images.arcpublishing.com/gray/XAJBQF2HNRBYZDKLKBUTZOTITY.jpg)
